Suppr超能文献

慢性肾衰竭患者血浆和尿液中的儿茶酚胺及其代谢产物

Plasma and urinary catecholamines and their metabolites in chronic renal failure.

作者信息

Darwish R, Elias A N, Vaziri N D, Pahl M, Powers D, Stokes J D

出版信息

Arch Intern Med. 1984 Jan;144(1):69-71.

PMID:6691776
Abstract

The effect of chronic renal failure (CRF) on the plasma concentration and urinary excretion of catecholamines and their metabolites was studied in 14 patients with varying degrees of chronic renal failure who had creatinine clearances of 19 to 77 mL/min. The results were compared with those obtained in a group of age-matched normal controls. Plasma catecholamine concentrations were significantly higher in the CRF patients compared with age-matched normal controls (456.9 +/- 303.1 v 278.5 +/- 81.1 pg/mL). The urinary metanephrine (0.6 +/- 0.6 mg/g creatinine) and vanillylmandelic acid (VMA) (6.6 +/- 4.2 mg/g creatinine) were within the normal range. No significant correlations were found between creatinine clearance and urinary metanephrine and VMA excretion or with the plasma catecholamine concentrations. Our observations indicate that, despite the decrease in creatinine clearance, urinary VMA and metanephrine determinations are valid screening tests for pheochromocytoma in patients with compromised renal function. Plasma catecholamine concentrations, however, show moderate elevation with decreasing renal function.

摘要

对14例肌酐清除率为19至77 mL/分钟、患有不同程度慢性肾衰竭(CRF)的患者,研究了慢性肾衰竭对儿茶酚胺及其代谢产物血浆浓度和尿排泄的影响。将结果与一组年龄匹配的正常对照者所得结果进行比较。与年龄匹配的正常对照者相比,CRF患者的血浆儿茶酚胺浓度显著更高(456.9±303.1对278.5±81.1 pg/mL)。尿间甲肾上腺素(0.6±0.6 mg/g肌酐)和香草扁桃酸(VMA)(6.6±4.2 mg/g肌酐)在正常范围内。肌酐清除率与尿间甲肾上腺素和VMA排泄或血浆儿茶酚胺浓度之间未发现显著相关性。我们的观察结果表明,尽管肌酐清除率降低,但尿VMA和间甲肾上腺素测定对于肾功能受损患者的嗜铬细胞瘤是有效的筛查试验。然而,血浆儿茶酚胺浓度随肾功能下降呈中度升高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验